ABH · NSE · Healthcare & Hospital Services
ABH Healthcare IPO listed on 01 Sep 2026 on NSE at ₹300.00, a gain of 20.00% over the issue price of ₹102.00. The IPO was subscribed 1.44x overall.
ABH Healthcare IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 24 Aug 2026 |
| IPO Close Date | 27 Aug 2026 |
| Basis of Allotment | 28 Aug 2026 |
| Initiation of Refunds | 31 Aug 2026 |
| Credit of Shares to Demat | 31 Aug 2026 |
| Listing Date | 01 Sep 2026 |
Listing day gain
+20%
Listed at ₹300 (issue ₹250)
Issue
₹250
Listing
₹300
Current
₹308.4
+23.36% vs issue
Day range
₹292.5 – ₹315
Issue Size
3,429,600 shares
(aggregating up to ₹35.00 Cr)
Issue Price
₹96 – ₹102
Face Value
₹10/share
Market Lot
1,200 shares
Retail Min Investment
₹244,800
Listing At
NSE
Sale Type
fresh issue
Fresh Issue
3,256,800 shares
(aggregating up to ₹33 Cr)
Offer for Sale
[.]
Reserved for Market Maker
172,800 shares
(aggregating up to ₹2.00 Cr)
Issue Type
book building
Open Date
24 Aug
Close Date
27 Aug
Allotment
28 Aug
Listing
01 Sep
Last updated: 1 month ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 31 Aug 2026 Latest | ₹102 | ₹0 | ₹102 | ₹0 |
0%
|
5:21 PM |
| 31 Aug 2026 | ₹102 | ₹0 | ₹102 | ₹0 |
0%
|
4:50 PM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 27 Aug 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 8.37x | - |
| NII | 0.29x | - |
| bNII (bids above ₹10L) | 0.15x | - |
| sNII (bids below ₹10L) | 0.55x | - |
| Individual Investors | 1.69x | - |
| Total | 1.44x | - |
Showing the latest subscription snapshot.
View full subscription historyDr. Kamal Baghi, Dr. Saurabh Baghi, and Dr. Vaishali Saini are the company promoters.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹244,800 |
| Retail (Max) | 2 | 2,400 | ₹244,800 |
| S-HNI (Min) | 3 | 3,600 | ₹367,200 |
| S-HNI (Max) | 8 | 9,600 | ₹979,200 |
| B-HNI (Min) | 9 | 10,800 | ₹1,101,600 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 199,200 (5.81%) |
| NII (HNI) Shares Offered | 1,528,800 (44.58%) |
|
•
bNII > ₹10L
|
1,018,800 (29.71%) |
|
•
sNII < ₹10L
|
510,000 (14.87%) |
| Individual Investors Shares Offered | 1,528,800 (44.57%) |
| Market Maker Shares Offered | 172,800 (5.04%) |
| Total Shares Offered | 3,429,600 (100.00%) |
ABH Healthcare Limited was originally incorporated as ABH Healthcare Private Limited on March 2, 2021, and is headquartered in Firozpur, Punjab. It works in the hospital and healthcare services sector.
The company operates a multi-speciality hospital under the name Anil Baghi Hospital, which it took over from a sole proprietorship run by promoter Dr. Kamal Baghi through a business transfer agreement dated March 16, 2022. The hospital has 150 beds and offers 25 medical specialities, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology and ENT. It is empanelled with 30 private and public health insurers and third-party administrators, and participates in government healthcare schemes such as the Ex-Servicemen Contributory Health Scheme, Ayushman Bharat - Sarbat Sehat Bima Yojana, and schemes for Railways, Food Corporation of India and BSNL employees. As of March 31, 2025, the hospital had 29 doctors and 137 nurses, with a total workforce of about 233 employees. The company is promoted by Dr. Kamal Baghi, Dr. Saurabh Baghi and Dr. Vaishali Saini.
Revenue stood at Rs 49.32 crore in FY25, up from about Rs 41 crore in FY24. This is an SME IPO, proposed to be listed on the NSE Emerge platform. The issue is entirely a fresh issue of up to 34,29,000 equity shares of face value Rs 10 each, with the price band yet to be determined. Net proceeds from the fresh issue are proposed to be used for repayment or prepayment, in part or full, of certain of the company's borrowings, with the balance for general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2023 | FY Mar 2024 | FY Dec 2024 |
|---|---|---|---|
| Total Revenue | 41.39 | 29.61 | 3.5 |
| Profit After Tax (PAT) | 1.66 | 0.71 | 0.09 |
| EBITDA | 4.05 | 6.89 | 8.99 |
| Total Assets | 51.35 | 32.96 | 26.27 |
| Net Worth | 4.62 | 6.3 | 9.58 |
| Reserves & Surplus | 2.7 | 4.35 | 7.67 |
| Total Borrowing | 20.99 | 35.83 | 39.67 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2024 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 30.33% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 14.96% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 30.33% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 4% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 16.66% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 5.28x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | - | ₹117 Cr |
The basis of allotment for ABH Healthcare IPO was finalised on 28 Aug 2026. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The ABH Healthcare IPO is expected to open in Aug 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for ABH Healthcare IPO is ₹96.00 - ₹102.00 per share.
As per market sources, ABH Healthcare IPO GMP is currently ₹0.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for ABH Healthcare IPO stands at 1.44x overall.
The listing date for ABH Healthcare IPO is 01 Sep 2026.
No comments yet. Be the first to comment!